5266-20-6
Chemical Structure
Lithium orotate
- CAS No.: 5266-20-6
- Formula:C5H3LiN2O4
- Molecular Weight:162.03
IUPAC Name: 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, lithium salt
InChIKey: IZJGDPULXXNWJP-UHFFFAOYSA-M
SMILES: O=C1C=C(C(O[Li])=O)NC(N1)=O
Biological Activity: Lithium orotate is an orally active lithium supplement with reduced binding that can bypass amyloid sequestration in AD mice models. Lithium orotate can prevent Aβ plaque deposition and phospho-tau accumulation and reverse AD pathology, neuroinflammatory changes and memory loss in AD mice models and ageing wild-type mice. Lithium orotate can be used for the research of alcoholism and Alzheimer’s disease[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lithium orotate | 99.82% | Lithium orotate is an orally active lithium supplement with reduced binding that can bypass amyloid sequestration in AD mice models. Lithium orotate can prevent Aβ plaque deposition and phospho-tau accumulation and reverse AD pathology, neuroinflammatory changes and memory loss in AD mice models and ageing wild-type mice. Lithium orotate can be used for the research of alcoholism and Alzheimer’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
